Explaining CKD Progression and Lab Trends to Patients

The problem

Explaining chronic kidney disease (CKD) progression to patients is one of the most repeated conversations in nephrology. Patients come to each visit with a printout of their blood results, often anxious, sometimes having looked up their numbers online and arrived convinced they are in crisis. Others arrive dismissive — their results have been "slightly off" for years and they have stopped taking it seriously.

The conversation takes time. The concept of eGFR as a percentage of expected kidney function is not intuitive. The idea that a slow, stable decline is different from a rapid one requires explanation. The same number in two different patients means something very different depending on the trajectory.

Writing a follow-up letter that captures what you said in the consultation — clearly, calmly, and in terms the patient will remember when they read it at home — is valuable. Writing one from scratch after every clinic appointment is not realistic.

How AI helps

An AI tool can draft a plain-language explanation of a CKD trajectory from a brief anonymised description of the trend. You describe the direction and pace of change, the current stage, and the key messages you want to convey. The tool drafts. You review for clinical accuracy, adjust the tone for this patient, and use it.

The tool is particularly useful for producing letters that are honest about trajectory without being alarming, and that explain what the numbers mean in practical terms — what this means for daily life, what the patient can do, and what happens next.

A real example

Dr Miriam is a consultant nephrologist. She has just seen a 65-year-old man with CKD Stage 3b due to diabetic nephropathy. His eGFR has declined from 42 to 36 over the past twelve months — gradual but consistent. He has been stable for years before this and is asking whether this means he is "getting worse." She wants to send a letter that explains what is happening without alarming him unnecessarily.

She opens Claude and types:

Draft a patient letter explaining CKD (chronic kidney disease) 
progression for a man in his mid-sixties.

Context: CKD Stage 3b due to diabetic nephropathy. eGFR has declined 
from 42 to 36 over the past 12 months — gradual and consistent.

The letter should:
- Explain what eGFR measures in plain English
- Explain what Stage 3b means
- Explain the difference between a slow stable decline and a rapid one
- Acknowledge that the numbers have changed but contextualise this honestly
- Describe what he can do: blood pressure control, diabetes management, 
  dietary adjustments, avoiding nephrotoxic substances
- Explain that monitoring continues and when he will next be reviewed
- Not include specific lab values (he has those from the clinic letter)
- Not make dietary recommendations beyond general principles

Tone: honest, calm, and not alarming. Maximum 350 words.

The tool produces a draft. Dr Miriam reads it. She adjusts one sentence that describes Stage 3b as "moderate kidney disease" — she prefers "reduced kidney function that needs careful monitoring," which she finds less loaded. She adds a line about the importance of blood pressure targets. The letter is ready in eight minutes.

Try it yourself

Things to watch for

The tool does not know this patient's full clinical picture. A patient with rapidly progressing CKD and multiple comorbidities needs a very different letter from one with slow stable decline. The tool works from what you tell it. Be specific about the trend and the clinical context in your prompt.

"Stage" language requires careful calibration. CKD staging language can be alarming if not framed carefully. The tool may describe Stage 3b as "moderate CKD" — which is technically accurate but may not be the framing you want. Check the staging language in the draft and adjust to match your preferred clinical communication style.

The tool may overstate what the patient can do. AI tools tend toward encouragement. For a patient with rapidly progressing CKD where lifestyle factors have limited impact, over-emphasising what the patient can do may be inadvertently misleading. Read the "what you can do" section carefully.

Dietary advice should be left to the dietitian. The draft should mention general principles only. Specific dietary guidance — particular potassium thresholds, phosphate restrictions — should come through your dietitian and through specific dietary counselling letters, not through a general CKD education letter.

Remember: AI is a helpful assistant, not a clinician. You make the call.